Skip to main content
. 2016 May 16;2016:2961954. doi: 10.1155/2016/2961954

Figure 5.

Figure 5

Metformin protects against HG + H/R induced cardiac cell injury by inhibiting JNK signaling pathway, which acts downstream of AMPK. H9C2 cells were treated with HG + H/R, metformin (5 mM), metformin + HG + H/R, compound C (1 μM), metformin + HG + H/R + compound C, ANISO (10 μM), and metformin + HG + H/R + ANISO. (a) Expression of P-JNK and T-JNK in each of the treatment conditions was measured by Western blots. (b) Effect of a putative JNK activator ANISO on cell viability was determined using the CCK-8 kit. Data are shown as means ± SD of 3 independent experiments. P < 0.05 versus control; # P < 0.05 versus HG + H/R; & P < 0.05 versus metformin + HG + H/R.